NewGenIvf Group Limited (NASDAQ:NIVF – Free Report) – Research analysts at Zacks Research issued their FY2026 earnings per share (EPS) estimates for shares of NewGenIvf Group in a research note issued to investors on Wednesday, April 1st. Zacks Research analyst B. Sorensen expects that the company will post earnings per share of $4.74 for the year. Zacks Research also issued estimates for NewGenIvf Group’s FY2027 earnings at $9.34 EPS and FY2028 earnings at $14.70 EPS.
A number of other analysts have also recently commented on NIVF. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Wednesday, January 28th. Wall Street Zen upgraded NewGenIvf Group to a “hold” rating in a research note on Saturday, December 6th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.
NewGenIvf Group Trading Down 1.4%
Shares of NIVF stock opened at $2.13 on Friday. The stock’s fifty day moving average is $3.18 and its 200-day moving average is $31.63. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.37 and a current ratio of 3.43. NewGenIvf Group has a 52 week low of $1.52 and a 52 week high of $4,440.00.
NewGenIvf Group Company Profile
NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.
NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.
Featured Articles
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.
